Forward this page to a friend

New Company at the University of Copenhagen Banks on Development of Extremely Effective Vaccines

Vaccine researchers from the University of Copenhagen have just founded a company by the name of “AdaptVac Aps” for the development of new, improved vaccines for the treatment of a number of serious diseases, including breast cancer. The company is a joint venture with the Danish biotech company ExpreS2ion Biotechnologies ApS with a view to commercial development.